Three peptides in one vial: GHK-Cu, BPC-157, and TB-500. One injection a day.
Not FDA-approved · Investigational use
The Glow Protocol combines three peptides in a single vial: GHK-Cu (the copper tripeptide), BPC-157, and TB-500 (a synthetic 7-amino-acid fragment of thymosin beta-4). It is used as a once-daily subcutaneous injection.
The thinking behind the combination is that the three peptides act on different but overlapping pathways: collagen and dermal matrix support from GHK-Cu, tissue and gut effects from BPC-157, and angiogenic and migration-related effects from TB-500. Patients who want both skin-quality work and broader tissue support sometimes prefer a single shot to running three separate protocols.
There is no published peer-reviewed literature on this exact three-peptide combination. The evidence for each individual component is what we have to work from. We’re honest about that with every patient who asks. The combination format is a clinical convenience, not a clinically validated formulation.
Response is individual; we don’t guarantee outcomes.
Daily dosing is the point of this protocol. One injection covers three peptides at once, which is why patients pick it over running three separate vials. The 8 to 12 week cycle gives the slower-moving effects (skin remodeling, hair density) time to show up.
Patients who are already using a topical GHK-Cu serum often continue that during the cycle, especially around microneedling and laser sessions. The topical and the injectable work different parts of the same problem.
Two things to flag honestly. There is no published study on this exact three-peptide combination. And TB-500 is on WADA’s prohibited substance list (S2). We don’t recommend this protocol for anyone subject to drug testing.
Most patients who pursue the Glow Protocol are already invested in their skin and want a single peptide layer that runs in the background. Some are also dealing with recurring soft-tissue issues, joint discomfort, or gut symptoms and prefer one injection over three.
We’re cautious in patients with active or recent cancer, copper sensitivity, pregnancy, and in any tested athlete. We discuss the evidence picture honestly before starting.
The Glow Protocol runs alongside hands-on aesthetic work. This protocol is often used to supplement other services like SkinPen microneedling, RF microneedling, ProFractional, Contour TRL, and our broader laser series.
Glow Protocol are not FDA-approved drugs. The peptides used in this protocol are sourced from specialty peptide distributors that perform Certificate of Analysis (COA) testing on every lot to confirm identity, purity, and concentration, and that operate under the regulatory and quality standards applicable to their industry. They have not been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease, and we treat their use as investigational and as part of an individualized wellness plan. The information on this page reflects published research, clinical experience, and what patients have reported. It is not a medical claim or a guarantee of any outcome.
If you want a single daily peptide that covers skin and tissue support together, and you want an honest read on the evidence, a consultation is the right place to start.
Schedule a Consultation
Expert provider-led care.
Answers from Dr. Oliver Morris, Medical Director at Olympia Aesthetics & Wellness in Palm Harbor.
Three peptides in a single vial: GHK-Cu, the copper tripeptide, plus BPC-157 and TB-500, a synthetic 7-amino-acid fragment of thymosin beta-4. You take it as one subcutaneous injection a day, in the abdomen. The thinking behind combining them is that they act on different but overlapping pathways. GHK-Cu supports collagen and the dermal matrix, BPC-157 has tissue and gut effects, and TB-500 has angiogenic and migration-related effects. Patients who want skin-quality work and broader tissue support sometimes prefer one shot to running three separate protocols. Be clear about what the combination is and is not. Putting them in one vial is a clinical convenience, not a clinically validated formulation. Wellness protocols here are supervised by Dr. Oliver Morris, our Medical Director.
No. None of the three peptides in the Glow Protocol are FDA-approved drugs, and that is the first thing we tell patients. They have not been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease, and we treat their use as investigational and as part of an individualized wellness plan. Sourcing is where the real quality question sits. Our peptides come through specialty peptide distributors that perform Certificate of Analysis testing on every lot to confirm identity, purity, and concentration, and that operate under the regulatory and quality standards applicable to their industry. What we would warn you off is the unprescribed vial ordered online. There is no way to verify what is in it, how pure it is, or whether it is sterile.
No published peer-reviewed literature exists on this specific three-peptide combination. We say that to every patient who asks, and we would rather lead with it than have you find out later. What we have to work from is the evidence for each individual component, and that evidence is uneven. GHK-Cu carries the most rigorous published work, mostly in dermatology and cosmetic literature and mostly on the topical form. The combination format is a clinical convenience, a way to cover three peptides in one daily injection, not a validated formulation with its own trial data behind it. If that gap bothers you, that is a reasonable reaction, and running GHK-Cu on its own is a legitimate alternative worth discussing at your consultation.
Most patients describe skin and recovery changes in weeks 4 to 8 of consistent use. A typical cycle runs 8 to 12 weeks with breaks between courses, and that length is deliberate. The slower-moving effects, skin remodeling and hair density in particular, need time to show up. What patients report over a cycle: improvements in skin texture, tone, and firmness, subjective gains in hair density and scalp condition, better recovery around aesthetic procedures, and support for tendons, joints, and gut comfort. Effects build rather than switch on. Response is individual and we do not guarantee outcomes. Patients already using a topical GHK-Cu serum usually keep using it during the cycle, especially around microneedling and laser sessions.
No, and this one is not a judgment call. TB-500 is on WADA's prohibited substance list under S2, so we do not recommend the Glow Protocol for anyone subject to drug testing. That covers competitive athletes in tested sports and anyone else whose organization tests against the WADA list. If you are in that group and you want the skin-quality side of this protocol, GHK-Cu on its own is the conversation to have instead. A few other groups we are cautious with: patients with active or recent cancer, anyone with copper sensitivity, and patients who are pregnant or breastfeeding. Injection-site reactions and a short-term flush are possible in some users. Tell us upfront if you are tested, because it changes the recommendation.
Pricing is set at your consultation rather than published, because the plan drives the number. A cycle runs 8 to 12 weeks of once-daily injections, and cycle length, dosing, and whether you are layering it on top of procedures all change what you would actually spend. Most patients who pursue this are already invested in their skin, running lasers or microneedling, and the Glow Protocol is one line in a larger plan. It is worth pricing the whole plan rather than the vial in isolation. One question worth asking at that visit is whether the combination is what you want at all, or whether GHK-Cu alone fits better. That choice affects both the cost and the evidence you are relying on.